{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:17:15Z","timestamp":1792513035051,"version":"4.5.0"},"reference-count":265,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002147","name":"International Life Sciences Institute Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000139","name":"U.S. Environmental Protection Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioadv.2026.214987","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:35:07Z","timestamp":1780328107000},"page":"214987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Towards advancing cancer nanomedicine: Recent strategies for overcoming translational and toxicological challenges"],"prefix":"10.1016","volume":"188","author":[{"given":"Muhammad","family":"Sohail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Younas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengkai","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0005","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41565-024-01803-1","article-title":"Targeted intervention in nerve\u2013cancer crosstalk enhances pancreatic cancer chemotherapy","volume":"20","author":"Qin","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"12","key":"10.1016\/j.bioadv.2026.214987_bb0015","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/14737140.2021.1991316","article-title":"Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy","volume":"21","author":"Sohail","year":"2021","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.bioadv.2026.214987_bb0020","article-title":"Recent advances in cancer nanomedicine: from smart targeting to personalized therapeutics-pioneering a new era in precision oncology","volume":"36","author":"Younas","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/jfb13030100","article-title":"Hydroxyapatite nanoparticles for improved cancer theranostics","volume":"13","author":"Kargozar","year":"2022","journal-title":"J. Funct. Biomater."},{"issue":"12","key":"10.1016\/j.bioadv.2026.214987_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16121582","article-title":"Precisely tailoring molecular structure of doxorubicin prodrugs to enable stable nanoassembly, rapid activation, and potent antitumor effect","volume":"16","author":"Feng","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2026.214987_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2022.10.023","article-title":"Current perspectives and trend of nanomedicine in cancer: a review and bibliometric analysis","volume":"352","author":"Pei","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s44222-025-00358-7","article-title":"Targeting metastasis with nanomedicine","volume":"4","author":"Pallares","year":"2026","journal-title":"Nat.. Rev. Bioeng."},{"key":"10.1016\/j.bioadv.2026.214987_bb0045","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S588669","article-title":"Nanomedicine targeting cancer-associated fibroblasts in prostate cancer: from biological mechanisms to integrated theranostic strategies","volume":"21","author":"Qian","year":"2026","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03442-7","article-title":"Nano-formulations in disease therapy: designs, advances, challenges, and future directions","volume":"23","author":"Shi","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214987_bb0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4155\/tde-2017-0118","article-title":"Nanomedicine: is it lost in translation?","volume":"9","author":"Greish","year":"2018","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.bioadv.2026.214987_bb0060","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jconrel.2024.07.067","article-title":"Nanomaterials for bone metastasis","volume":"373","author":"Hao","year":"2024","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb0065","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1021\/acsnano.9b08133","article-title":"Nanomaterials for nanotheranostics: tuning their properties according to disease needs","volume":"14","author":"Wong","year":"2020","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214987_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.chempr.2025.102706","article-title":"Cancer nanomedicine: concepts, promises, and challenges","volume":"11","author":"Zhu","year":"2025","journal-title":"Chem"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214987_bb0075","doi-asserted-by":"crossref","first-page":"7953","DOI":"10.1021\/acsnano.2c12448","article-title":"Nanoarchitecture-integrated hydrogel systems toward therapeutic applications","volume":"17","author":"Zhu","year":"2023","journal-title":"ACS Nano"},{"issue":"13","key":"10.1016\/j.bioadv.2026.214987_bb0080","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1021\/acsaelm.5c00842","article-title":"Transforming computational nanotechnology: accelerating material discovery, design, and property prediction through soft computing techniques","volume":"7","author":"Das","year":"2025","journal-title":"ACS Appl. Electron. Mater."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214987_bb0085","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1021\/acsnano.4c09566","article-title":"Transforming medicine: cutting-edge applications of nanoscale materials in drug delivery","volume":"19","author":"Tenchov","year":"2025","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.medj.2022.12.001","article-title":"Cancer nanomedicine toward clinical translation: obstacles, opportunities, and future prospects","volume":"4","author":"Zhang","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.bioadv.2026.214987_bb0095","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2020.08.012","article-title":"Controlled anti-cancer drug release through advanced nano-drug delivery systems: static and dynamic targeting strategies","volume":"327","author":"Kashkooli","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214987_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114449","article-title":"Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms","volume":"188","author":"Zi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2026.214987_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214987_bb0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","article-title":"Targeted drug delivery strategies for precision medicines","volume":"6","author":"Manzari","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bioadv.2026.214987_bb0115","article-title":"Brain-targeting drug delivery systems: the state of the art in treatment of glioblastoma","volume":"30","author":"Sun","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.688","article-title":"Endogenous\/exogenous stimuli-responsive smart hydrogels for diabetic wound healing","volume":"6","author":"Khattak","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.bioadv.2026.214987_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103961","article-title":"A critical review on the dissemination of PH and stimuli-responsive polymeric nanoparticular systems to improve drug delivery in cancer therapy","volume":"185","author":"Bhattacharya","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/acsnano.4c05906","article-title":"pH-responsive polyethylene glycol engagers for enhanced brain delivery of PEGylated nanomedicine to treat glioblastoma","volume":"19","author":"Meng","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2026.214987_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123004","article-title":"Redox-activatable inhalable mucoadhesive proteinic nanotherapeutics for targeted treatment of lung cancer","volume":"316","author":"Jeong","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214987_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122196","article-title":"Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer","volume":"338","author":"Sharma","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioadv.2026.214987_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbon.2025.120099","article-title":"Self-amplifying ROS-responsive SN38 prodrug nanoparticles for combined chemotherapy and ferroptosis in cancer treatment","volume":"235","author":"Qin","year":"2025","journal-title":"Carbon"},{"key":"10.1016\/j.bioadv.2026.214987_bb0150","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.actbio.2023.05.037","article-title":"Allomelanin-based biomimetic nanotherapeutics for orthotopic glioblastoma targeted photothermal immunotherapy","volume":"166","author":"Sun","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2026.214987_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.155781","article-title":"Carrier-free multifunctional nanomedicine for enhanced hyperthermic intraperitoneal chemotherapy against abdominal pelvic tumors","volume":"498","author":"Fang","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"30","key":"10.1016\/j.bioadv.2026.214987_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202504986","article-title":"Cryo-inactivated cancer cells derived magnetic micromotors for tumor immunotherapy","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214987_bb0165","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.apsb.2025.03.046","article-title":"Metabolic reprogramming nanomedicine potentiates colon cancer sonodynamic immunotherapy by inhibiting the CD39\/CD73\/ADO pathway","volume":"15","author":"Zhang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202407833","article-title":"Concurrent amplification of ferroptosis and immune system activation via nanomedicine-mediated radiosensitization for triple-negative breast cancer therapy","volume":"12","author":"Aishajiang","year":"2025","journal-title":"Adv. Sci."},{"issue":"30","key":"10.1016\/j.bioadv.2026.214987_bb0175","first-page":"19581","article-title":"Electric field-responsive gold nanoantennas for the induction of a locoregional tumor pH change using electrolytic ablation therapy","volume":"18","author":"Joe","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0180","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41467-024-55658-0","article-title":"Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species","volume":"16","author":"Zou","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2026.214987_bb0185","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2147\/IJN.S466042","article-title":"Tumor cell-targeting and tumor microenvironment\u2013responsive nanoplatforms for the multimodal imaging-guided photodynamic\/photothermal\/chemodynamic treatment of cervical cancer","author":"Wang","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"19","key":"10.1016\/j.bioadv.2026.214987_bb0190","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.2174\/0929867327666201005111722","article-title":"Nanocarrier-based drug delivery system for cancer therapeutics: a review of the last decade","volume":"28","author":"Sohail","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"36","key":"10.1016\/j.bioadv.2026.214987_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202000673","article-title":"Safety considerations of cancer nanomedicine\u2014a key step toward translation","volume":"16","author":"Liu","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2026.214987_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2022.12.048","article-title":"Nanocomplexes of doxorubicin and DNA fragments for efficient and safe cancer chemotherapy","volume":"354","author":"Mohammad","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214987_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.137147","article-title":"Nanomedicines and nanomaterials for cancer therapy: progress, challenge and perspectives","volume":"446","author":"Jing","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioadv.2026.214987_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00360","article-title":"Nanomedicine: principles, properties, and regulatory issues","volume":"6","author":"Soares","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioadv.2026.214987_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101184","article-title":"Nanotoxicology and nanomedicine: the Yin and Yang of nano-bio interactions for the new decade","volume":"39","author":"Bondarenko","year":"2021","journal-title":"Nano Today"},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb0220","doi-asserted-by":"crossref","first-page":"9994","DOI":"10.1021\/acsnano.2c00128","article-title":"Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology","volume":"16","author":"Domingues","year":"2022","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0225","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cclet.2021.08.090","article-title":"Macrophage-targeted nanomedicine for chronic diseases immunotherapy","volume":"33","author":"Song","year":"2022","journal-title":"Chin. Chem. Lett."},{"issue":"10","key":"10.1016\/j.bioadv.2026.214987_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202511618","article-title":"Navigating the endothelial barrier: a multiscale framework for precision nanomedicine","volume":"22","author":"Ma","year":"2026","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202500624","article-title":"Nanomedicine for oral delivery: strategies to overcome the biological barriers","volume":"10","author":"Kubiatowicz","year":"2026","journal-title":"Small Methods"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0240","article-title":"Cancer-targeted nanomedicine: overcoming the barrier of the protein corona","volume":"3","author":"Barui","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bioadv.2026.214987_bb0245","first-page":"1","article-title":"Novel dual strategy based on EPR\/AT for optimizing therapeutic effect by improving drug delivery system physicochemical properties and regulating TME","author":"Chen","year":"2026","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0250","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1038\/s41467-025-63198-4","article-title":"Galloylated liposomes enable targeted drug delivery by overcoming protein corona shielding","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2026.214987_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122925","article-title":"Enhanced tumor-targeting ability of transferrin-functionalized magnetic nanoparticles by in vivo AMF stimulation","volume":"315","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0260","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imm.13793","article-title":"Immunotherapy and the ovarian cancer microenvironment: exploring potential strategies for enhanced treatment efficacy","volume":"173","author":"Wang","year":"2024","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.bioadv.2026.214987_bb0265","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/17425247.2026.2619094","article-title":"Clinical hurdles for curcumin and piperine nanoparticles in prostate cancer treatment: a bridge too far or a path to clinical reality?","volume":"23","author":"Yakubu","year":"2026","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bioadv.2026.214987_bb0270","doi-asserted-by":"crossref","first-page":"327","DOI":"10.54097\/9911t393","article-title":"Active targeting design and preclinical progress of liposome-based nanocarriers for cancer therapy","volume":"162","author":"Cao","year":"2026","journal-title":"Highl. Sci. Eng. Technol."},{"issue":"10","key":"10.1016\/j.bioadv.2026.214987_bb0275","doi-asserted-by":"crossref","first-page":"15627","DOI":"10.1021\/acsnano.2c05317","article-title":"How nanoparticles open the paracellular route of biological barriers: mechanisms, applications, and prospects","volume":"16","author":"Wu","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2026.214987_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125357","article-title":"Recent advances in cellulose, pectin, carrageenan and alginate-based oral drug delivery systems","volume":"244","author":"Raghav","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2026.214987_bb0285","article-title":"Lipid based drug delivery systems for oral, transdermal and parenteral delivery: recent strategies for targeted delivery consistent with different clinical application","volume":"85","author":"Srivastav","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2026.214987_bb0290","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.msec.2018.05.031","article-title":"Polyester based nanovehicles for siRNA delivery","volume":"92","author":"Xu","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0295","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1021\/acs.molpharmaceut.0c00287","article-title":"Nanomedicine for acute brain injuries: insight from decades of cancer nanomedicine","volume":"18","author":"Kandell","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2026.214987_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114450","article-title":"Extracellular vesicles for improved tumor accumulation and penetration","volume":"188","author":"Bie","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2026.214987_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2023.100158","article-title":"Fluid mechanics in circulating tumour cells: role in metastasis and treatment strategies","volume":"18","author":"Rajput","year":"2023","journal-title":"Med, Drug Discov."},{"key":"10.1016\/j.bioadv.2026.214987_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110302","article-title":"Grand challenges in nanomedicine","volume":"106","author":"Wu","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"issue":"17","key":"10.1016\/j.bioadv.2026.214987_bb0315","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/gt.2008.60","article-title":"The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer","volume":"15","author":"Wisse","year":"2008","journal-title":"Gene Ther."},{"issue":"17","key":"10.1016\/j.bioadv.2026.214987_bb0320","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1111\/bph.12604","article-title":"Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling","volume":"171","author":"Moss","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.214987_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101008","article-title":"Progress, challenges, and future of nanomedicine","volume":"35","author":"Zhang","year":"2020","journal-title":"Nano Today"},{"issue":"8","key":"10.1016\/j.bioadv.2026.214987_bb0330","article-title":"Nanomedicine reimagined: translational strategies for precision tumor theranostics","volume":"38","author":"Wu","year":"2025","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.bioadv.2026.214987_bb0335","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1039\/D4NR05298F","article-title":"Advanced disease therapeutics using engineered living drug delivery systems","volume":"17","author":"Mamidi","year":"2025","journal-title":"Nanoscale"},{"issue":"42","key":"10.1016\/j.bioadv.2026.214987_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202502667","article-title":"Engineered bionanomaterials for precision delivery of nucleic acid drugs","volume":"21","author":"Bian","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2026.214987_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114326","article-title":"Biodistribution, pharmacokinetics and excretion studies of intravenously injected nanoparticles and extracellular vesicles: possibilities and challenges","volume":"186","author":"Skotland","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214987_bb0350","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.nantod.2016.10.005","article-title":"Emerging understanding of the protein corona at the nano-bio interfaces","volume":"11","author":"Mahmoudi","year":"2016","journal-title":"Nano Today"},{"key":"10.1016\/j.bioadv.2026.214987_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215051","article-title":"Current understanding of passive and active targeting nanomedicines to enhance tumor accumulation","volume":"481","author":"Chen","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioadv.2026.214987_bb0360","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2021.11.024","article-title":"Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles","volume":"341","author":"Souri","year":"2022","journal-title":"J. Control. Release"},{"issue":"22","key":"10.1016\/j.bioadv.2026.214987_bb0365","doi-asserted-by":"crossref","first-page":"22366","DOI":"10.1021\/acsomega.5c01865","article-title":"The role of ROS in atherosclerosis and ROS-based nanotherapeutics for atherosclerosis: atherosclerotic lesion targeting, ROS scavenging, and ROS-responsive activity","volume":"10","author":"Qian","year":"2025","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.bioadv.2026.214987_bb0370","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1021\/acs.nanolett.7b00021","article-title":"Mediating passive tumor accumulation through particle size, tumor type, and location","volume":"17","author":"Perry","year":"2017","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb0375","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1021\/nl204175t","article-title":"Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation","volume":"12","author":"Smith","year":"2012","journal-title":"Nano Lett."},{"issue":"27","key":"10.1016\/j.bioadv.2026.214987_bb0380","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.1073\/pnas.0913667107","article-title":"Paradoxical glomerular filtration of carbon nanotubes","volume":"107","author":"Ruggiero","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214987_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.107891","article-title":"Sequentially responsive size reduction and drug release of core-satellite nanoparticles to enhance tumor penetration and effective tumor suppression","volume":"34","author":"Sun","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214987_bb0390","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bpj.2010.06.016","article-title":"Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions","volume":"99","author":"Stylianopoulos","year":"2010","journal-title":"Biophys. J."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0395","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.ddtec.2011.11.010","article-title":"Enhanced permeability and retention effect for selective targeting of anticancer nanomedicine: are we there yet?","volume":"9","author":"Greish","year":"2012","journal-title":"Drug Discov. Today Technol."},{"issue":"21","key":"10.1016\/j.bioadv.2026.214987_bb0400","doi-asserted-by":"crossref","first-page":"R1161","DOI":"10.1016\/j.cub.2016.09.043","article-title":"Exploring novel methods for modulating tumor blood vessels in cancer treatment","volume":"26","author":"Wong","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bioadv.2026.214987_bb0405","series-title":"Cancer Nanotechnology: Methods and Protocols","first-page":"25","article-title":"Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting","author":"Greish","year":"2010"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0410","article-title":"Current progress and remaining challenges of peptide\u2013drug conjugates (PDCs): next generation of antibody-drug conjugates (ADCs)?","volume":"23","author":"Wang","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb0415","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0420","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1080\/10717544.2022.2073403","article-title":"Complex polymeric nanomicelles co-delivering doxorubicin and dimethoxycurcumin for cancer chemotherapy","volume":"29","author":"Sohail","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioadv.2026.214987_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125068","article-title":"An antigen\/chemotherapy co-loaded DNA nanocube inserts into tumor cell plasma membrane and enhances chemo-and immunotherapy","volume":"669","author":"Cao","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0430","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1416","article-title":"Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials","volume":"9","author":"Caster","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bioadv.2026.214987_bb0435","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","article-title":"Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity","volume":"91","author":"Maeda","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214987_bb0440","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41563-020-0669-9","article-title":"A nanoparticle\u2019s pathway into tumours","volume":"19","author":"de L\u00e1zaro","year":"2020","journal-title":"Nat. Mater."},{"issue":"21","key":"10.1016\/j.bioadv.2026.214987_bb0445","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1073\/pnas.1307152110","article-title":"Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor","volume":"110","author":"Wiley","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioadv.2026.214987_bb0450","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3389\/fnins.2018.01019","article-title":"Transcytosis to cross the blood brain barrier, new advancements and challenges","volume":"12","author":"Pulgar","year":"2019","journal-title":"Front. Neurosci."},{"issue":"8","key":"10.1016\/j.bioadv.2026.214987_bb0455","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","article-title":"Enzyme-activatable polymer\u2013drug conjugate augments tumour penetration and treatment efficacy","volume":"14","author":"Zhou","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.bioadv.2026.214987_bb0460","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41551-021-00701-4","article-title":"Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion\u2013drug conjugates with cell-membrane affinity","volume":"5","author":"Chen","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"12","key":"10.1016\/j.bioadv.2026.214987_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202200173","article-title":"Multipotent poly (tertiary amine-oxide) micelles for efficient cancer drug delivery","volume":"9","author":"Xiang","year":"2022","journal-title":"Adv. Sci."},{"issue":"26","key":"10.1016\/j.bioadv.2026.214987_bb0470","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.7150\/thno.38587","article-title":"Transcytosis-an effective targeting strategy that is complementary to \u201cEPR effect\u201d for pancreatic cancer nano drug delivery","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.bioadv.2026.214987_bb0475","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214987_bb0480","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41563-020-0672-1","article-title":"Active transcytosis and new opportunities for cancer nanomedicine","volume":"19","author":"Pandit","year":"2020","journal-title":"Nat. Mater."},{"issue":"14","key":"10.1016\/j.bioadv.2026.214987_bb0485","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606628","article-title":"Rational design of cancer nanomedicine: nanoproperty integration and synchronization","volume":"29","author":"Sun","year":"2017","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0490","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/0115672018336038240930082554","article-title":"Nanoparticle-mediated transcytosis in tumor drug delivery: mechanisms, categories, and novel applications","volume":"23","author":"Doaa","year":"2024","journal-title":"Curr. Drug Deliv."},{"issue":"10","key":"10.1016\/j.bioadv.2026.214987_bb0495","doi-asserted-by":"crossref","first-page":"12281","DOI":"10.1021\/acsnano.9b09713","article-title":"What went wrong with anticancer nanomedicine design and how to make it right","volume":"14","author":"Sun","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2026.214987_bb0500","article-title":"Engineering the tumor immune landscape: translating non-invasive physical stimulation into tumor-associated macrophage-targeted cancer immunotherapy","author":"Zhang","year":"2026","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.bioadv.2026.214987_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115550","article-title":"Beyond the EPR effect: intravital microscopy analysis of nanoparticle drug delivery to tumors","volume":"219","author":"Belyaev","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2026.214987_bb0510","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","article-title":"Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine","volume":"143","author":"Donahue","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2026.214987_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114318","article-title":"Nano-bio interactions: a major principle in the dynamic biological processes of nano-assemblies","volume":"186","author":"Liu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2026.214987_bb0520","first-page":"1","article-title":"Better the devil you know than the devil you don\u2019t\u2014PEG challenges in nanomedicine","author":"Dobrovolskaia","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308977","article-title":"Nanomedicine combats drug resistance in lung cancer","volume":"36","author":"Zheng","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioadv.2026.214987_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110466","article-title":"Nanocarrier design\u2013function relationship: the prodigious role of properties in regulating biocompatibility for drug delivery applications","volume":"377","author":"Oladipo","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioadv.2026.214987_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106515","article-title":"Nanoparticles-based therapeutics for the management of bacterial infections: a special emphasis on FDA approved products and clinical trials","volume":"188","author":"Aflakian","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2026.214987_bb0540","doi-asserted-by":"crossref","DOI":"10.34133\/bmef.0120","article-title":"A systematic review of toxicity, biodistribution, and biosafety in upconversion nanomaterials: critical insights into toxicity mitigation strategies and future directions for safe applications","volume":"6","author":"Khan","year":"2025","journal-title":"BME Front."},{"key":"10.1016\/j.bioadv.2026.214987_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100704","article-title":"Nanomedicine to target multidrug resistant tumors","volume":"52","author":"Lepeltier","year":"2020","journal-title":"Drug Resist. Updat."},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb0550","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/10408440903120975","article-title":"Development of in vitro systems for nanotoxicology: methodological considerations","volume":"39","author":"Stone","year":"2009","journal-title":"Crit. Rev. Toxicol."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214987_bb0555","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nano.2013.02.011","article-title":"Nanomedicine and the complement paradigm","volume":"9","author":"Moghimi","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2026.214987_bb0560","series-title":"Characterization of Nanoparticles Intended for Drug Delivery","first-page":"149","article-title":"Analysis of complement activation by nanoparticles","author":"Neun","year":"2017"},{"key":"10.1016\/j.bioadv.2026.214987_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.603039","article-title":"Nanoparticle-induced complement activation: implications for cancer nanomedicine","volume":"11","author":"La-Beck","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bioadv.2026.214987_bb0570","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1039\/C5TB01825K","article-title":"Materials design at the interface of nanoparticles and innate immunity","volume":"4","author":"Szeto","year":"2016","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0575","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1074\/jbc.M110.180760","article-title":"Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces","volume":"286","author":"Pham","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb0580","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08982100802309552","article-title":"Liposome-mediated triggering of complement cascade","volume":"18","author":"Moghimi","year":"2008","journal-title":"J. Liposome Res."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214987_bb0585","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1582-4934.2008.00350.x","article-title":"The alternative complement pathway revisited","volume":"12","author":"Harboe","year":"2008","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.bioadv.2026.214987_bb0590","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.biomaterials.2009.01.005","article-title":"Immunocompatibility properties of lipid\u2013polymer hybrid nanoparticles with heterogeneous surface functional groups","volume":"30","author":"Salvador-Morales","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214987_bb0595","first-page":"35","article-title":"Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery","volume":"1","author":"Malachowski","year":"2020","journal-title":"Eng. Regen."},{"issue":"12","key":"10.1016\/j.bioadv.2026.214987_bb0600","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.addr.2011.06.017","article-title":"Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention","volume":"63","author":"Szebeni","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"13","key":"10.1016\/j.bioadv.2026.214987_bb0605","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1158\/0008-5472.CAN-14-0157","article-title":"Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche","volume":"74","author":"Vadrevu","year":"2014","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb0610","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.4049\/jimmunol.1602057","article-title":"The ribosomal protein S19 suppresses antitumor immune responses via the complement C5a receptor 1","volume":"198","author":"Markiewski","year":"2017","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.bioadv.2026.214987_bb0615","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-15-1412","article-title":"Autocrine complement inhibits IL10-dependent T-cell\u2013mediated antitumor immunity to promote tumor progression","volume":"6","author":"Wang","year":"2016","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0620","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.gendis.2022.12.021","article-title":"The generation and use of animal models of osteosarcoma in cancer research","volume":"11","author":"Pu","year":"2024","journal-title":"Genes Dis."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0625","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s42826-022-00128-1","article-title":"Role of animal models in biomedical research: a review","volume":"38","author":"Mukherjee","year":"2022","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.bioadv.2026.214987_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114708","article-title":"Nanoparticle biodistribution coefficients: a quantitative approach for understanding the tissue distribution of nanoparticles","volume":"194","author":"Kumar","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0635","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bcp.2013.06.020","article-title":"Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery","volume":"87","author":"Ruggeri","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.214987_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114962","article-title":"Evolution of nanomedicine formulations for targeted delivery and controlled release","volume":"200","author":"Puri","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2026.214987_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120807","article-title":"PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up","volume":"605","author":"Operti","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214987_bb0650","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","article-title":"Nanomedicine scale-up technologies: feasibilities and challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"10.1016\/j.bioadv.2026.214987_bb0655","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1080\/03639045.2020.1821055","article-title":"Bridging the gap: academia, industry and FDA convergence for nanomaterials","volume":"46","author":"Shah","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"36","key":"10.1016\/j.bioadv.2026.214987_bb0660","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.2174\/0929867328666210406115529","article-title":"Regulatory considerations, challenges and risk-based approach in nanomedicine development","volume":"28","author":"Cs\u00f3ka","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioadv.2026.214987_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115751","article-title":"Liposomes characterization for market approval as pharmaceutical products: analytical methods, guidelines and standardized protocols","volume":"236","author":"Giordani","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bioadv.2026.214987_bb0670","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.787239","article-title":"Nanomedicines and nanosimilars\u2014why a robust centralised regulatory framework is essential to enhance patient safety","volume":"12","author":"Isles","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.214987_bb0675","doi-asserted-by":"crossref","first-page":"13039","DOI":"10.2147\/IJN.S554821","article-title":"Bridging the gap: the role of advanced formulation strategies in the clinical translation of nanoparticle-based drug delivery systems","author":"Herdiana","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.bioadv.2026.214987_bb0680","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/17435889.2026.2645781","article-title":"Process and purification synergies with data analytics driving clinical translation in nanomedicine","volume":"21","author":"Kushwaha","year":"2026","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0685","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-021-01096-0","article-title":"Nanomaterials for cancer therapy: current progress and perspectives","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioadv.2026.214987_bb0690","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2019.07.006","article-title":"Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications","volume":"144","author":"Mohammadpour","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2026.214987_bb0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2017.10.008","article-title":"A systematic review on silver nanoparticles-induced cytotoxicity: physicochemical properties and perspectives","volume":"9","author":"Akter","year":"2018","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0700","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/toxsci\/kfx208","article-title":"Editor\u2019s highlight: a genome-wide screening of target genes against silver nanoparticles in fission yeast","volume":"161","author":"Lee","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bioadv.2026.214987_bb0705","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1034\/j.1600-0773.2000.d01-2.x","article-title":"Preclinical safety assessment: in vitro\u2013in vivo testing","volume":"86","author":"H\u00f8jelse","year":"2000","journal-title":"Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214987_bb0710","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.biomaterials.2011.10.070","article-title":"The cytotoxicity of cadmium-based quantum dots","volume":"33","author":"Chen","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214987_bb0715","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.552613","article-title":"Signaling pathways implicated in carbon nanotube-induced lung inflammation","volume":"11","author":"Dong","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb0720","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1039\/C3NR05772K","article-title":"Immunotoxicity of nanoparticles: a computational study suggests that CNTs and C 60 fullerenes might be recognized as pathogens by Toll-like receptors","volume":"6","author":"Turabekova","year":"2014","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0725","doi-asserted-by":"crossref","DOI":"10.1186\/1743-8977-8-10","article-title":"Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells","volume":"8","author":"Pujalt\u00e9","year":"2011","journal-title":"Part. Fibre Toxicol."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214987_bb0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217022","article-title":"Shape of ligand immobilized particles dominates and amplifies the macrophage cytokine response to ligands","volume":"14","author":"Garapaty","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bioadv.2026.214987_bb0735","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.2147\/IJN.S443168","article-title":"Long-term accumulation, biological effects and toxicity of BSA-coated gold nanoparticles in the mouse liver, spleen, and kidneys","author":"Jakic","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"23","key":"10.1016\/j.bioadv.2026.214987_bb0740","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.2217\/nnm-2019-0253","article-title":"In vivo comparison of the biodistribution and long-term fate of colloids\u2013gold nanoprisms and nanorods\u2013with minimum surface modification","volume":"14","author":"Alfranca","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2026.214987_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.164840","article-title":"Uptake, bioaccumulation, biodistribution and depuration of polystyrene nanoplastics in zebrafish (Danio rerio)","volume":"893","author":"Habumugisha","year":"2023","journal-title":"Sci. Total Environ."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214987_bb0750","first-page":"477","article-title":"Features of toxic effect due to biodistribution and bio-accumulation of nano-and microparticles of copper (II) oxide","volume":"103","author":"Zemlyanova","year":"2024","journal-title":"Hyg. Sanit."},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb0755","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/dmd.122.000980","article-title":"Biodistribution of lipid 5, mRNA, and its translated protein following intravenous administration of mRNA-encapsulated lipid nanoparticles in rats","volume":"51","author":"Ci","year":"2023","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb0760","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s44222-023-00047-3","article-title":"Engineering nanomaterial physical characteristics for cancer immunotherapy","volume":"1","author":"Lee","year":"2023","journal-title":"Nat.. Rev. Bioeng."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb0765","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/nn304332s","article-title":"Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment","volume":"7","author":"Wang","year":"2013","journal-title":"ACS Nano"},{"issue":"23","key":"10.1016\/j.bioadv.2026.214987_bb0770","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1039\/c3nr02140h","article-title":"Modulation of the pharmacokinetics of zinc oxide nanoparticles and their fates in vivo","volume":"5","author":"Paek","year":"2013","journal-title":"Nanoscale"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0775","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2011.09.041","article-title":"Surface modified nevirapine nanosuspensions for viral reservoir targeting: in vitro and in vivo evaluation","volume":"421","author":"Shegokar","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0780","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nano.2012.06.002","article-title":"In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles","volume":"9","author":"Simpson","year":"2013","journal-title":"Nanomedicine"},{"issue":"sup2","key":"10.1016\/j.bioadv.2026.214987_bb0785","first-page":"3","article-title":"Organization of research team for nano-associated safety assessment in effort to study nanotoxicology of zinc oxide and silica nanoparticles","volume":"9","author":"Kim","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0790","doi-asserted-by":"crossref","DOI":"10.1186\/1743-8977-2-8","article-title":"Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy","volume":"2","author":"Oberd\u00f6rster","year":"2005","journal-title":"Part. Fibre Toxicol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0795","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1097\/01.mjt.0000433947.16654.75","article-title":"Toxicological concerns of engineered nanosize drug delivery systems","volume":"23","author":"Mukherjee","year":"2016","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.bioadv.2026.214987_bb0800","series-title":"Titanium and Gold Nanoparticles in Asthma: The Bad and the Ugly","first-page":"225","author":"Lanone","year":"2011"},{"issue":"10","key":"10.1016\/j.bioadv.2026.214987_bb0805","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/thoraxjnl-2020-214523","article-title":"Airspace dimension assessment with nanoparticles as a proposed biomarker for emphysema","volume":"76","author":"Aaltonen","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.bioadv.2026.214987_bb0810","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jhazmat.2013.01.046","article-title":"Comparative study of respiratory tract immune toxicity induced by three sterilisation nanoparticles: silver, zinc oxide and titanium dioxide","volume":"248","author":"Liu","year":"2013","journal-title":"J. Hazard. Mater."},{"issue":"44","key":"10.1016\/j.bioadv.2026.214987_bb0815","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108131118","article-title":"Serum apolipoprotein AI depletion is causative to silica nanoparticles\u2013induced cardiovascular damage","volume":"118","author":"Liu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioadv.2026.214987_bb0820","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.aquatox.2015.02.002","article-title":"Effects of titanium dioxide nanoparticles on lead bioconcentration and toxicity on thyroid endocrine system and neuronal development in zebrafish larvae","volume":"161","author":"Miao","year":"2015","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.bioadv.2026.214987_bb0825","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tox.2016.07.007","article-title":"Influence of a low dose of silver nanoparticles on cerebral myelin and behavior of adult rats","volume":"363","author":"D\u0105browska-Bouta","year":"2016","journal-title":"Toxicology"},{"issue":"10","key":"10.1016\/j.bioadv.2026.214987_bb0830","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1021\/nn302502u","article-title":"Peptide-functionalized gold nanorods increase liver injury in hepatitis","volume":"6","author":"Bartneck","year":"2012","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0835","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/08958378.2013.871762","article-title":"Toxicity of quantum dots on respiratory system","volume":"26","author":"Wu","year":"2014","journal-title":"Inhal. Toxicol."},{"issue":"25","key":"10.1016\/j.bioadv.2026.214987_bb0840","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.1039\/c1cc10692a","article-title":"Some aspects of quantum dot toxicity","volume":"47","author":"Bottrill","year":"2011","journal-title":"Chem. Commun."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0845","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/psc.1290","article-title":"Carbon nanotube-coupled cell adhesion peptides are non-immunogenic: a promising step toward new biomedical devices","volume":"17","author":"Gaillard","year":"2011","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.bioadv.2026.214987_bb0850","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.toxrep.2016.01.011","article-title":"Toxicity determinants of multi-walled carbon nanotubes: the relationship between functionalization and agglomeration","volume":"3","author":"Allegri","year":"2016","journal-title":"Toxicol. Rep."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0855","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11051-009-9692-0","article-title":"Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions","volume":"12","author":"Villiers","year":"2010","journal-title":"J. Nanopart. Res."},{"issue":"11","key":"10.1016\/j.bioadv.2026.214987_bb0860","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/smll.200700378","article-title":"Size-dependent cytotoxicity of gold nanoparticles","volume":"3","author":"Pan","year":"2007","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0865","doi-asserted-by":"crossref","DOI":"10.3402\/nano.v1i0.5358","article-title":"Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)","volume":"1","author":"Singh","year":"2010","journal-title":"Nano Rev."},{"issue":"8","key":"10.1016\/j.bioadv.2026.214987_bb0870","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/ijms17081193","article-title":"Accumulation and toxicity of superparamagnetic iron oxide nanoparticles in cells and experimental animals","volume":"17","author":"Jarockyte","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2026.214987_bb0875","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tox.2007.12.022","article-title":"Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells","volume":"245","author":"Park","year":"2008","journal-title":"Toxicology"},{"issue":"9\u201310","key":"10.1016\/j.bioadv.2026.214987_bb0880","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/smll.201201531","article-title":"Applications and potential toxicity of magnetic iron oxide nanoparticles","volume":"9","author":"Liu","year":"2013","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb0885","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ygyno.2013.09.031","article-title":"Clinical risk factors of PEGylated liposomal doxorubicin induced palmar plantar erythrodysesthesia in recurrent ovarian cancer patients","volume":"131","author":"Ko","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0890","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jconrel.2010.08.030","article-title":"Route of administration-dependent anti-inflammatory effect of liposomal alendronate","volume":"148","author":"Haber","year":"2010","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214987_bb0895","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3390\/molecules22091401","article-title":"Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy","volume":"22","author":"Palmerston Mendes","year":"2017","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bioadv.2026.214987_bb0900","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/0883911511425567","article-title":"In vivo biodistribution of carboxymethylchitosan\/poly (amidoamine) dendrimer nanoparticles in rats","volume":"26","author":"Pereira","year":"2011","journal-title":"J. Bioact. Compat. Polym."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb0905","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2009.02.011","article-title":"Histological study on side effects and tumor targeting of a block copolymer micelle on rats","volume":"136","author":"Kawaguchi","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214987_bb0910","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cbi.2016.12.014","article-title":"Evaluation of in vitro toxicity of polymeric micelles to human endothelial cells under different conditions","volume":"263","author":"Liu","year":"2017","journal-title":"Chem. Biol. Interact."},{"issue":"17","key":"10.1016\/j.bioadv.2026.214987_bb0915","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1021\/cm901259n","article-title":"Synthesis and characterization of biocompatible and size-tunable multifunctional porous silica nanoparticles","volume":"21","author":"Lin","year":"2009","journal-title":"Chem. Mater."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb0920","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/su17031250","article-title":"An overview on the role of government initiatives in nanotechnology innovation for sustainable economic development and research progress","volume":"17","author":"Khatoon","year":"2025","journal-title":"Sustainability"},{"issue":"4\u20136","key":"10.1016\/j.bioadv.2026.214987_bb0925","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/20468954.2025.2470103","article-title":"PLGA and cancer: a comprehensive patent-based review on the present state of art","volume":"13","author":"Nath","year":"2024","journal-title":"Pharm. Pat. Anal."},{"key":"10.1016\/j.bioadv.2026.214987_bb0930","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1702392","article-title":"Patent landscape of nanotechnology\u2013based nucleic acid delivery systems for breast cancer therapies","volume":"15","author":"Silva","year":"2026","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214987_bb0935","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1872210517666230613154847","article-title":"Emerging nanotechnology-based therapeutics: a new insight into promising drug delivery system for lung cancer therapy","volume":"18","author":"Verma","year":"2024","journal-title":"Recent Pat. Nanotechnol."},{"issue":"10","key":"10.1016\/j.bioadv.2026.214987_bb0940","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/13543776.2023.2287520","article-title":"Nanoparticles in pancreatic cancer therapy: a detailed and elaborated review on patent literature","volume":"33","author":"Singh","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0945","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/pharmaceutics16020221","article-title":"Recent technological and intellectual property trends in antibody\u2013drug conjugate research","volume":"16","author":"Choi","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb0950","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/pharmaceutics14010106","article-title":"Development of pharmaceutical nanomedicines: from the bench to the market","volume":"14","author":"Halwani","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214987_bb0955","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of cancer nanomedicines\u2014lessons learned from successes and failures","volume":"52","author":"He","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioadv.2026.214987_bb0960","series-title":"Nano-oncologicals: New Targeting and Delivery Approaches","first-page":"425","article-title":"Regulatory aspects of oncologicals: nanosystems main challenges","author":"Gaspar","year":"2014"},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb0965","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.apsb.2022.02.025","article-title":"Current approaches of nanomedicines in the market and various stage of clinical translation","volume":"12","author":"Shan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioadv.2026.214987_bb0970","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2019.08.008","article-title":"Pharmacokinetics of nanotechnology-based formulations in pediatric populations","volume":"151","author":"Yellepeddi","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2026.214987_bb0975","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/jcph.1138","article-title":"Drug formulations: standards and novel strategies for drug administration in pediatrics","volume":"58","author":"Thabet","year":"2018","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214987_bb0980","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb0985","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX\u2122\/Doxil\u00ae) versus conventional doxorubicin for first-line treatment of metastatic breast cancer","volume":"15","author":"O\u2019Brien","year":"2004","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.bioadv.2026.214987_bb0990","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1517\/14656566.3.12.1739","article-title":"Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy","volume":"3","author":"Batist","year":"2002","journal-title":"Expert. Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214987_bb0995","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/cncr.21662","article-title":"Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a phase III multicenter randomized trial","volume":"106","author":"Rifkin","year":"2006","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.bioadv.2026.214987_bb1000","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/annonc\/mdm374","article-title":"Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer","volume":"18","author":"Kim","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bioadv.2026.214987_bb1005","series-title":"Seminars in Oncology","article-title":"Advantages of liposomal delivery systems for anthracyclines","author":"Allen","year":"2004"},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb1010","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/cas.15377","article-title":"Liposomal irinotecan (Onivyde): exemplifying the benefits of nanotherapeutic drugs","volume":"113","author":"Milano","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioadv.2026.214987_bb1015","first-page":"99","article-title":"Albumin-bound formulation of paclitaxel (Abraxane\u00ae ABI-007) in the treatment of breast cancer","author":"Miele","year":"2009","journal-title":"Int. J. Nanomedicine"},{"issue":"18","key":"10.1016\/j.bioadv.2026.214987_bb1020","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1016\/j.bmc.2014.02.035","article-title":"Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function","volume":"22","author":"Field","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioadv.2026.214987_bb1025","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1586\/era.09.69","article-title":"Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma","volume":"9","author":"Meyers","year":"2009","journal-title":"Expert. Rev. Anticancer. Ther."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb1030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/11204910-000000000-00000","article-title":"Mifamurtide: a review of its use in the treatment of osteosarcoma","volume":"12","author":"Frampton","year":"2010","journal-title":"Pediatr. Drugs"},{"issue":"1\u20133","key":"10.1016\/j.bioadv.2026.214987_bb1035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0169-409X(00)00134-4","article-title":"SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy","volume":"46","author":"Maeda","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.bioadv.2026.214987_bb1040","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1080\/02656736.2018.1430867","article-title":"Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans","volume":"34","author":"Mahmoudi","year":"2018","journal-title":"Int. J. Hyperth."},{"issue":"9","key":"10.1016\/j.bioadv.2026.214987_bb1045","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1158\/1078-0432.CCR-18-2990","article-title":"FDA approval summary:(daunorubicin and cytarabine) liposome for injection for the treatment of adults with high-risk acute myeloid leukemia","volume":"25","author":"Krauss","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb1050","article-title":"Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine","volume":"2019","author":"Lombardo","year":"2019","journal-title":"J. Nanomater."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb1055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11060-012-0880-x","article-title":"Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series","volume":"109","author":"Chamberlain","year":"2012","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bioadv.2026.214987_bb1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114172","article-title":"Merging data curation and machine learning to improve nanomedicines","volume":"183","author":"Chen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2026.214987_bb1065","series-title":"Revolutionizing Healthcare Services","first-page":"142","article-title":"Advancing healthcare through artificial intelligence: pioneering solutions and impactful applications","author":"Kumar","year":"2025"},{"key":"10.1016\/j.bioadv.2026.214987_bb1070","series-title":"Spherical Nucleic Acids","first-page":"1687","article-title":"Exploration of the nanomedicine-design space with high-throughput screening and machine learning","author":"Yamanluirt","year":"2020"},{"issue":"6","key":"10.1016\/j.bioadv.2026.214987_bb1075","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1208\/s12249-014-0172-1","article-title":"Novel orally swallowable IntelliCap\u00ae device to quantify regional drug absorption in human GI tract using diltiazem as model drug","volume":"15","author":"Becker","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb1080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41587-021-01024-0","article-title":"Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors","volume":"40","author":"Abramson","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb1085","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41928-021-00614-9","article-title":"Wireless on-demand drug delivery","volume":"4","author":"Mirvakili","year":"2021","journal-title":"Nat. Electron."},{"issue":"37","key":"10.1016\/j.bioadv.2026.214987_bb1090","doi-asserted-by":"crossref","first-page":"33288","DOI":"10.1021\/acsnano.5c09066","article-title":"TuNa-AI: a hybrid kernel machine to design tunable nanoparticles for drug delivery","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2026.214987_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135123","article-title":"Development of fucoidan\/polyethyleneimine based sorafenib-loaded self-assembled nanoparticles with machine learning and DoE-ANN implementation: optimization, characterization, and in-vitro assessment for the anticancer drug delivery","volume":"279","author":"Chaurawal","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2026.214987_bb1100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123879","article-title":"Oral delivery of posaconazole-loaded phospholipid-based nanoformulation: preparation and optimization using design of experiments, machine learning, and TOPSIS","volume":"653","author":"Bayat","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb1105","first-page":"130","article-title":"Machine learning for predictive modeling in nanomedicine-based cancer drug delivery","volume":"2","author":"Sahu","year":"2026","journal-title":"Med. Res."},{"issue":"7","key":"10.1016\/j.bioadv.2026.214987_bb1110","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/17425247.2025.2502022","article-title":"Explicating the transformative role of artificial intelligence in designing targeted nanomedicine","volume":"22","author":"Akhtar","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb1115","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.56028\/aetr.14.1.1503.2025","article-title":"Machine learning-driven anticancer drug discovery: from virtual screening to preclinical validation","volume":"14","author":"Wang","year":"2025","journal-title":"Adv. Eng. Technol. Res."},{"key":"10.1016\/j.bioadv.2026.214987_bb1120","article-title":"Digital twins: a new paradigm in oncology in the era of big data","volume":"5","author":"Mollica","year":"2024","journal-title":"ESMO Real World Data Digit. Oncol."},{"key":"10.1016\/j.bioadv.2026.214987_bb1125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.781499","article-title":"Digital twin technology: the future of predicting neurological complications of pediatric cancers and their treatment","volume":"11","author":"Thiong\u2019o","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioadv.2026.214987_bb1130","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2022.1007784","article-title":"Exploring approaches for predictive cancer patient digital twins: opportunities for collaboration and innovation","volume":"4","author":"Stahlberg","year":"2022","journal-title":"Front. Digit. Health"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb1135","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1038\/s41598-024-55228-w","article-title":"Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology","volume":"14","author":"Eminaga","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2026.214987_bb1140","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2022.826402","article-title":"Developing a cancer digital twin: supervised metastases detection from consecutive structured radiology reports","volume":"5","author":"Batch","year":"2022","journal-title":"Front. Artif. Intell."},{"key":"10.1016\/j.bioadv.2026.214987_bb1145","series-title":"Cost\u2013Effectiveness of Nanomedicine: The Path to a Future Successful and Dominant Market?","first-page":"1851","author":"Bosetti","year":"2015"},{"key":"10.1016\/j.bioadv.2026.214987_bb1150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2019.05.011","article-title":"Predicting the critical quality attributes of ibuprofen tablets via modelling of process parameters for roller compaction and tabletting","volume":"565","author":"Matji","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2026.214987_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119436","article-title":"3D-printed microfluidic chip for the preparation of glycyrrhetinic acid-loaded ethanolic liposomes","volume":"584","author":"Tiboni","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214987_bb1160","doi-asserted-by":"crossref","DOI":"10.1002\/admt.201800511","article-title":"High throughput nanoliposome formation using 3D printed microfluidic flow focusing chips","volume":"4","author":"Chen","year":"2019","journal-title":"Adv. Mater. Technol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb1165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41378-021-00277-8","article-title":"Tumor-on-a-chip: from bioinspired design to biomedical application","volume":"7","author":"Liu","year":"2021","journal-title":"Microsyst. Nanoeng."},{"key":"10.1016\/j.bioadv.2026.214987_bb1170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2016.03.008","article-title":"Tumor penetrating peptides for improved drug delivery","volume":"110","author":"Ruoslahti","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb1175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12943-023-01784-0","article-title":"New opportunities for RGD-engineered metal nanoparticles in cancer","volume":"22","author":"Qin","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bioadv.2026.214987_bb1180","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nbt.3506","article-title":"An injectable nanoparticle generator enhances delivery of cancer therapeutics","volume":"34","author":"Xu","year":"2016","journal-title":"Nat. Biotechnol."},{"issue":"260","key":"10.1016\/j.bioadv.2026.214987_bb1185","doi-asserted-by":"crossref","first-page":"260ra149","DOI":"10.1126\/scitranslmed.3009524","article-title":"Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe","volume":"6","author":"Phillips","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"15","key":"10.1016\/j.bioadv.2026.214987_bb1190","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1002\/ange.201612647","article-title":"Interactions of renal-clearable gold nanoparticles with tumor microenvironments: vasculature and acidity effects","volume":"129","author":"Yu","year":"2017","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bioadv.2026.214987_bb1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112503","article-title":"Cell membrane-based biomimetic nanosystems for advanced drug delivery in cancer therapy: a comprehensive review","volume":"215","author":"Zhao","year":"2022","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"6","key":"10.1016\/j.bioadv.2026.214987_bb1200","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1285","article-title":"Cell membrane-coated nanoparticles for the treatment of cancer","volume":"13","author":"Krishnan","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"11","key":"10.1016\/j.bioadv.2026.214987_bb1205","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1021\/acsabm.0c01014","article-title":"Biomimetic mesoporous silica nanoparticles for enhanced blood circulation and cancer therapy","volume":"3","author":"Peng","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bioadv.2026.214987_bb1210","article-title":"Cell membrane-camouflaged nanomedicines for enhanced thrombolysis and blood-brain barrier penetration in ischemic stroke therapy","volume":"10","author":"Chen","year":"2025","journal-title":"Int. J. Pharm.: X"},{"key":"10.1016\/j.bioadv.2026.214987_bb1215","article-title":"Biomimetic exosomes: a new generation of drug delivery system","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb1220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/mr-2023-0007","article-title":"Promoting the bench-to-bedside translation of nanomedicines","volume":"3","author":"Zhang","year":"2023","journal-title":"Med. Rev."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb1225","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/acs.nanolett.0c04753","article-title":"A biomimetic drug delivery system by integrating grapefruit extracellular vesicles and doxorubicin-loaded heparin-based nanoparticles for glioma therapy","volume":"21","author":"Niu","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioadv.2026.214987_bb1230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152249","article-title":"Recent advances in nanopharmaceutical strategies for cancer treatment","volume":"777","author":"Khalid","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb1235","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214987_bb1240","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/153303460500400608","article-title":"Role of nanobiotechnology in developing personalized medicine for cancer","volume":"4","author":"Jain","year":"2005","journal-title":"Technol. Cancer Res. Treat."},{"issue":"12","key":"10.1016\/j.bioadv.2026.214987_bb1245","doi-asserted-by":"crossref","first-page":"13620","DOI":"10.1021\/acsnano.9b08659","article-title":"Nanomedicines lost in translation","volume":"13","author":"Guidolin","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2026.214987_bb1250","article-title":"Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2","volume":"21","author":"Parker","year":"2019","journal-title":"Nanomedicine"},{"issue":"24","key":"10.1016\/j.bioadv.2026.214987_bb1255","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1002\/smll.201301417","article-title":"Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model","volume":"9","author":"Karra","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2026.214987_bb1260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2014.07.046","article-title":"Translation from mouse to human: time to think in new boxes","volume":"189","author":"Park","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214987_bb1265","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107556","article-title":"Advancing precision therapy for colorectal cancer: developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models","volume":"211","author":"Tang","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb1270","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tibtech.2017.12.001","article-title":"Rational design of mouse models for cancer research","volume":"36","author":"Landgraf","year":"2018","journal-title":"Trends Biotechnol."},{"issue":"9","key":"10.1016\/j.bioadv.2026.214987_bb1275","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/mi6091249","article-title":"Recent advances in applications of droplet microfluidics","volume":"6","author":"Chou","year":"2015","journal-title":"Micromachines"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214987_bb1280","doi-asserted-by":"crossref","DOI":"10.1063\/5.0087294","article-title":"The impact of microfluidics in high-throughput drug-screening applications","volume":"16","author":"De Stefano","year":"2022","journal-title":"Biomicrofluidics"},{"issue":"4","key":"10.1016\/j.bioadv.2026.214987_bb1285","doi-asserted-by":"crossref","first-page":"042001","DOI":"10.1088\/1758-5090\/ad5f55","article-title":"Skin-on-a-chip technologies towards clinical translation and commercialization","volume":"16","author":"Ismayilzada","year":"2024","journal-title":"Biofabrication"},{"key":"10.1016\/j.bioadv.2026.214987_bb1290","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S595349","article-title":"Cardiotoxicity challenges in nanomaterial: risk assessment, mechanisms, and mitigation strategies","volume":"21","author":"Li","year":"2026","journal-title":"Int. J. Nanomedicine"},{"issue":"6","key":"10.1016\/j.bioadv.2026.214987_bb1295","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1039\/C8TX00156A","article-title":"A 3D human lung-on-a-chip model for nanotoxicity testing","volume":"7","author":"Zhang","year":"2018","journal-title":"Toxicol. Res."},{"issue":"12","key":"10.1016\/j.bioadv.2026.214987_bb1300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243840","article-title":"Microfluidics and organ-on-a-chip technologies: a systematic review of the methods used to mimic bone marrow","volume":"15","author":"Santos Rosalem","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bioadv.2026.214987_bb1305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biomaterials.2017.11.010","article-title":"A nephron model for study of drug-induced acute kidney injury and assessment of drug-induced nephrotoxicity","volume":"155","author":"Qu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214987_bb1310","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120683","article-title":"A multi-niche microvascularized human bone marrow (hBM) on-a-chip elucidates key roles of the endosteal niche in hBM physiology","volume":"270","author":"Nelson","year":"2021","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.bioadv.2026.214987_bb1315","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1039\/C5LC00392J","article-title":"A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents","volume":"15","author":"Maschmeyer","year":"2015","journal-title":"Lab Chip"},{"key":"10.1016\/j.bioadv.2026.214987_bb1320","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.836984","article-title":"Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine","volume":"10","author":"Yee","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214987_bb1325","doi-asserted-by":"crossref","DOI":"10.5528\/wjtm.v12.i1.113050","article-title":"Tumor organoids in translational cancer research: models for personalized therapy","volume":"12","author":"Agrawal","year":"2026","journal-title":"World J. Transl. Med."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826002852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826002852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T21:30:49Z","timestamp":1786051849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826002852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":265,"alternative-id":["S2772950826002852"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214987","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards advancing cancer nanomedicine: Recent strategies for overcoming translational and toxicological challenges","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"214987"}}